propranolol has been researched along with Arteriosclerosis, Coronary in 15 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In selected population of 113 patients with effort angina and proven coronary artery disease, the coronary cineangiographic pattern after 2 year therapy with nifedipine (Group 1, 39 patients), propranolol (Group 2, 36 patients), or isosorbide dinitrate (control group, 38 patients) was compared to the pre-treatment pattern." | 7.67 | [Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates]. ( De Cesare, N; Fabbiocchi, F; Guazzi, M; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A; Ravagnani, P, 1989) |
| "We have previously shown that administration of a relatively large weight-based IC dose of the beta blocker propranolol before PCI decreases the incidence of post-PCI myocardial infarction (MI) and improves short- and long-term outcome." | 5.13 | Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. ( Akhtar, A; Anzuini, A; Birnbaum, Y; Chamoun, A; Gupta, R; Kumar, D; Lev, E; Lui, C; McGehee, T; Osman, A; Paniagua, O; Pohwani, A; Schwarz, ER; Uretsky, BF; Wang, FW, 2008) |
| "The effect of intracoronary and intravenous propranolol on coronary vasomotion was evaluated in 30 patients with coronary artery disease." | 3.67 | [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise]. ( Bortone, A; Chiddo, A; Gaglione, A; Hess, OM; Locuratolo, N; Rizzon, P; Troito, G, 1989) |
| " In selected population of 113 patients with effort angina and proven coronary artery disease, the coronary cineangiographic pattern after 2 year therapy with nifedipine (Group 1, 39 patients), propranolol (Group 2, 36 patients), or isosorbide dinitrate (control group, 38 patients) was compared to the pre-treatment pattern." | 3.67 | [Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates]. ( De Cesare, N; Fabbiocchi, F; Guazzi, M; Guazzi, MD; Loaldi, A; Montorsi, P; Polese, A; Ravagnani, P, 1989) |
| "The intramural coronary arteriosclerosis showed thickening of the wall due to medial hyperplasia by fibrosis, and arterial stenosis." | 1.33 | Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat. ( Hikasa, Y; Minami, S; Morita, T; Okamoto, Y; Shimada, A; Tsujino, K, 2005) |
| "Propranolol was the only intervention that produced a significant decrease in diastolic pulmonary artery pressure (16 +/- 5 to 11 +/- 3 mmHg, P < 0." | 1.33 | Different effects of propranolol, phenylephrine, and saline volume loading on catecholamine-induced left ventricular outflow tract obstruction in acute coronary syndrome. ( Hamasaki, S; Minagoe, S; Ohba, I; Otsuji, Y; Shiki, K; Tei, C, 2006) |
| "Oxprenolol treatment did not modify the blood pressure levels in the renal hypertensive rats nor in the spontaneously hypertensive turkeys." | 1.28 | Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension. ( Dal Palù, C; Pauletto, P; Pessina, AC; Scannapieco, G; Vescovo, G, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uretsky, BF | 2 |
| Birnbaum, Y | 1 |
| Osman, A | 2 |
| Gupta, R | 1 |
| Paniagua, O | 1 |
| Chamoun, A | 1 |
| Pohwani, A | 1 |
| Lui, C | 1 |
| Lev, E | 1 |
| McGehee, T | 1 |
| Kumar, D | 1 |
| Akhtar, A | 1 |
| Anzuini, A | 2 |
| Schwarz, ER | 1 |
| Wang, FW | 2 |
| Chen, CM | 1 |
| Liu, YC | 1 |
| Chen, CC | 1 |
| Wen, MS | 1 |
| Hung, CF | 1 |
| Wan, YL | 1 |
| Otero, J | 1 |
| Stouffer, GA | 1 |
| Waxman, S | 1 |
| Afzal, A | 1 |
| Tsujino, K | 1 |
| Hikasa, Y | 1 |
| Minami, S | 1 |
| Okamoto, Y | 1 |
| Morita, T | 1 |
| Shimada, A | 1 |
| Ohba, I | 1 |
| Otsuji, Y | 1 |
| Shiki, K | 1 |
| Hamasaki, S | 1 |
| Minagoe, S | 1 |
| Tei, C | 1 |
| Just, H | 1 |
| Frey, M | 1 |
| Piatak, OA | 2 |
| Yanovskii, GV | 1 |
| Lizogub, VG | 2 |
| Murohara, T | 1 |
| Yasue, H | 1 |
| Ohgushi, M | 1 |
| Sakaino, N | 1 |
| Jougasaki, M | 1 |
| Kozlov, VV | 1 |
| Pauletto, P | 1 |
| Vescovo, G | 1 |
| Scannapieco, G | 1 |
| Pessina, AC | 1 |
| Dal Palù, C | 1 |
| Loaldi, A | 2 |
| Montorsi, P | 2 |
| Fabbiocchi, F | 2 |
| Polese, A | 2 |
| Guazzi, M | 2 |
| De Cesare, N | 2 |
| Guazzi, MD | 2 |
| Bortone, A | 1 |
| Hess, OM | 1 |
| Gaglione, A | 1 |
| Locuratolo, N | 1 |
| Troito, G | 1 |
| Rizzon, P | 1 |
| Chiddo, A | 1 |
| Ravagnani, P | 1 |
| Nabel, EG | 1 |
| Ganz, P | 1 |
| Gordon, JB | 1 |
| Alexander, RW | 1 |
| Selwyn, AP | 1 |
| Moshkin, AP | 1 |
| Rudaseva, LP | 1 |
1 review available for propranolol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery Disease; Diltiazem; Humans; Nife | 1994 |
4 trials available for propranolol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Artery Disea | 2008 |
Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Coronary Artery Di | 2003 |
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Tes | 1991 |
Angiographic evolution of coronary atherosclerosis in patients receiving propranolol. A two-year follow-up.
Topics: Angina Pectoris; Angiography, Digital Subtraction; Coronary Angiography; Coronary Artery Disease; Fe | 1991 |
10 other studies available for propranolol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Radiation dose exposure of patients undergoing 320-row cardiac CT for assessing coronary angiography and global left ventricular function.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cardiac-Gated Imaging Techniques; Coronary Angiograp | 2012 |
Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat.
Topics: Animals; Aorta, Abdominal; Benzazepines; Cat Diseases; Cats; Coronary Artery Disease; Diltiazem; Dip | 2005 |
Different effects of propranolol, phenylephrine, and saline volume loading on catecholamine-induced left ventricular outflow tract obstruction in acute coronary syndrome.
Topics: Adrenergic beta-Antagonists; Angina, Unstable; Animals; Coronary Artery Disease; Dobutamine; Dogs; H | 2006 |
Age related attenuation of the endothelium dependent relaxation to noradrenaline in isolated pig coronary arteries.
Topics: Aging; Animals; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Endothe | 1991 |
[Cardiohemodynamics and microcirculation in patients with ischemic heart disease undergoing beta-adrenergic receptor stimulation and blockade].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Conjunctiva; Coronary Artery Disease; Drug Ev | 1990 |
Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Calcium-Transporting ATPases; Cardiomeg | 1990 |
[Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Exerc | 1989 |
[Angiographic course of coronary atherosclerosis in angina pectoris. Its relation to 2 years' treatment with propranolol, nifedipine and nitrates].
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Isosorbide Dinit | 1989 |
Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.
Topics: Adult; Aged; Angiography; Cold Temperature; Coronary Angiography; Coronary Artery Disease; Coronary | 1988 |
[Electrophoresis of obzidan and magnesium in the combined sanatorium-health resort treatment of patients with hypertension].
Topics: Adult; Combined Modality Therapy; Coronary Artery Disease; Female; Health Resorts; Humans; Hypertens | 1988 |